Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Knudsen

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
BMC Cancer|October 23, 2019
Validation of computational determination of microsatellite status using whole exome sequencing data from colorectal cancer patientsAmanda Frydendahl Boll Johansen, Christine Gaasdal Kassentoft, Michael Knudsen, et al.
Sexual Development : Genetics, Molecular Biology, Evolution, Endocrinology, Embryology, and Pathology of Sex Determination and Differentiation|December 4, 2017
A Rare Case of Embryonal Carcinoma in a Patient with Turner Syndrome without Y Chromosomal Material but Mutations in KIT, AKT1, and ZNF358 Demonstrated Using Exome SequencingClaus H Gravholt, Ole L Dollerup, Lone Duval, et al.
International Journal of Cancer|April 11, 2024
Exploring the tumor genomic landscape of aggressive prostate cancer by whole-genome sequencing of tissue or liquid biopsiesSimone Weiss, Philippe Lamy, Maria Rusan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2023
Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder CancerEmil Christensen, Iver Nordentoft, Karin Birkenkamp-Demtröder, et al.
European Urology|September 17, 2023
Field Cancerization Is Associated with Tumor Development, T-cell Exhaustion, and Clinical Outcomes in Bladder CancerTrine Strandgaard, Iver Nordentoft, Karin Birkenkamp-Demtröder, et al.
Nature Communications|September 26, 2020
Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysisAnn Taber, Emil Christensen, Philippe Lamy, et al.
Scientific Reports|August 10, 2019
Correlation between early dynamics in circulating tumour DNA and outcome from FOLFIRI treatment in metastatic colorectal cancerIben Lyskjær, Camilla Skovhus Kronborg, Mads Heilskov Rasmussen, et al.
Nature Communications|April 5, 2022
Author Correction: Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysisAnn Taber, Emil Christensen, Philippe Lamy, et al.
Journal of Clinical Immunology|September 30, 2025
Diagnostic and Monitoring Strategies for VEXAS Syndrome: Evaluating Sanger Sequencing, NGS, and the SWIM-ScoreLasse von Bornemann Fløe, Kirstine Overgaard Dyrmose, Camilla Darum Sørensen, et al.
International Journal of Cancer|January 7, 2022
Circulating tumor DNA for prognosis assessment and postoperative management after curative-intent resection of colorectal liver metastasesThomas Reinert, Lena Marie Skindhøj Petersen, Tenna Vesterman Henriksen, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
BMC Cancer|October 23, 2019
Validation of computational determination of microsatellite status using whole exome sequencing data from colorectal cancer patientsAmanda Frydendahl Boll Johansen, Christine Gaasdal Kassentoft, Michael Knudsen, et al.
Sexual Development : Genetics, Molecular Biology, Evolution, Endocrinology, Embryology, and Pathology of Sex Determination and Differentiation|December 4, 2017
A Rare Case of Embryonal Carcinoma in a Patient with Turner Syndrome without Y Chromosomal Material but Mutations in KIT, AKT1, and ZNF358 Demonstrated Using Exome SequencingClaus H Gravholt, Ole L Dollerup, Lone Duval, et al.
International Journal of Cancer|April 11, 2024
Exploring the tumor genomic landscape of aggressive prostate cancer by whole-genome sequencing of tissue or liquid biopsiesSimone Weiss, Philippe Lamy, Maria Rusan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2023
Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder CancerEmil Christensen, Iver Nordentoft, Karin Birkenkamp-Demtröder, et al.
European Urology|September 17, 2023
Field Cancerization Is Associated with Tumor Development, T-cell Exhaustion, and Clinical Outcomes in Bladder CancerTrine Strandgaard, Iver Nordentoft, Karin Birkenkamp-Demtröder, et al.
Nature Communications|September 26, 2020
Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysisAnn Taber, Emil Christensen, Philippe Lamy, et al.
Scientific Reports|August 10, 2019
Correlation between early dynamics in circulating tumour DNA and outcome from FOLFIRI treatment in metastatic colorectal cancerIben Lyskjær, Camilla Skovhus Kronborg, Mads Heilskov Rasmussen, et al.
Nature Communications|April 5, 2022
Author Correction: Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysisAnn Taber, Emil Christensen, Philippe Lamy, et al.
Journal of Clinical Immunology|September 30, 2025
Diagnostic and Monitoring Strategies for VEXAS Syndrome: Evaluating Sanger Sequencing, NGS, and the SWIM-ScoreLasse von Bornemann Fløe, Kirstine Overgaard Dyrmose, Camilla Darum Sørensen, et al.
International Journal of Cancer|January 7, 2022
Circulating tumor DNA for prognosis assessment and postoperative management after curative-intent resection of colorectal liver metastasesThomas Reinert, Lena Marie Skindhøj Petersen, Tenna Vesterman Henriksen, et al.
Pageof 4